bimokalner (ACOU085) / Acousia Therapeutics - LARVOL DELTA

Promising First-in-Patient Results for ACOU085 (INN: Bimokalner) in Cisplatin-Induced Ototoxicity (PRNewswire) - "In patients who developed ototoxicity, treatment with ACOU085 resulted in a clinically meaningful prevention of pure-tone audiometry (PTA) threshold increases at affected frequencies, compared to placebo, following the final cisplatin cycle. Further analysis of the PROHEAR Study results, including post-hoc evaluations, is ongoing and will be submitted for publication in a peer-reviewed journal."

P2 data • Oncology • Otorhinolaryngology • Testicular Cancer